JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 55 filers reported holding JANUX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $14,438,310 | +10.5% | 344,672 | -0.7% | 0.00% | 0.0% |
| Q1 2024 | $13,070,989 | +2949.4% | 347,171 | +769.1% | 0.00% | – |
| Q4 2023 | $428,642 | +192.4% | 39,948 | +174.7% | 0.00% | – |
| Q3 2023 | $146,604 | -45.6% | 14,544 | -36.0% | 0.00% | – |
| Q2 2023 | $269,675 | +40.2% | 22,719 | +55.6% | 0.00% | – |
| Q4 2022 | $192,322 | +101122.1% | 14,603 | +4.0% | 0.00% | – |
| Q3 2022 | $190 | -2.1% | 14,047 | -11.5% | 0.00% | – |
| Q2 2022 | $194 | -99.9% | 15,864 | -11.5% | 0.00% | – |
| Q1 2022 | $257,000 | -11.7% | 17,934 | +21.6% | 0.00% | – |
| Q4 2021 | $291,000 | -83.1% | 14,748 | -78.6% | 0.00% | – |
| Q2 2021 | $1,722,000 | – | 69,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |